Access

Insight

Nature 451, 949-952 (21 February 2008) | doi:10.1038/nature06802; Published online 20 February 2008

Open Innovation Challenges

naturejobs

Progress Article The search for new cardiovascular biomarkers

Robert E. Gerszten1,2 & Thomas J. Wang2

Top

Despite considerable advances in the treatment of cardiovascular disease, it remains the leading cause of death in developed countries. Assessment of classic cardiovascular risk factors — including high blood pressure, diabetes and smoking — has a central role in disease prevention. However, many individuals with coronary heart disease (a narrowing of the blood vessels that supply the heart) have only one, or none, of the classic risk factors. Thus, new biomarkers are needed to augment the information obtained from traditional indicators and to illuminate disease mechanisms.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Diagnostics The prostate-cancer metabolome

Nature News and Views (12 Feb 2009)

Acute coronary syndromes BNP measurement predicts AMI risk in the elderly

Nature Reviews Cardiology News and Views (01 Aug 2009)

Bringing metabolomics data into the forefront of systems biology

Molecular Systems Biology News and Views (20 Jun 2006)

From biomarkers to integrated network responses

Nature Biotechnology News and Views (01 Oct 2008)